Literature DB >> 23584191

Participation in opioid substitution treatment reduces the rate of criminal convictions: evidence from a community study.

Helena Vorma1, Petteri Sokero, Mikko Aaltonen, Saija Turtiainen, Lorine A Hughes, Jukka Savolainen.   

Abstract

OBJECTIVE: Positive outcomes associated with opioid substitution treatment include reduced illicit opioid use and lower risk of HIV and other blood-borne infections. The effect on the reduction of criminal activity remains unclear. Our aim was to investigate the impact of treatment on criminal activity using conviction register data.
METHOD: This observational retrospective study included all new patients (N=169) enrolled in an opioid substitution treatment program in the Helsinki University Central Hospital Clinic for Addiction Psychiatry between 2000 and 2005. Psychiatric and psychosocial services were provided as part of the program. Patient treatments were followed up for 18 months. Data on criminal convictions were collected for approximately 3 years before and after the start of treatment.
RESULTS: Mean rates of convictions decreased significantly during treatment. The effects were similar for total convictions, drug convictions, and property crime convictions. Although the numbers of violence and drunk driving convictions were too small to be analysed separately, on a bivariate level there was no indication of reduction in these crime types. Patients with amphetamine co-dependence fared best. Sex, age, other co-dependences or psychiatric diagnoses, negative urine analyses during the treatment, and dropping out from treatment had little impact on the outcomes.
CONCLUSIONS: Opioid substitution treatment seems to reduce criminal activity effectively. However, more information is needed to determine how treatment influences different types of criminality and which types of patients benefit most.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23584191     DOI: 10.1016/j.addbeh.2013.03.009

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  7 in total

1.  Only One In Twenty Justice-Referred Adults In Specialty Treatment For Opioid Use Receive Methadone Or Buprenorphine.

Authors:  Noa Krawczyk; Caroline E Picher; Kenneth A Feder; Brendan Saloner
Journal:  Health Aff (Millwood)       Date:  2017-12       Impact factor: 6.301

Review 2.  Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.

Authors:  Lucy Platt; Silvia Minozzi; Jennifer Reed; Peter Vickerman; Holly Hagan; Clare French; Ashly Jordan; Louisa Degenhardt; Vivian Hope; Sharon Hutchinson; Lisa Maher; Norah Palmateer; Avril Taylor; Julie Bruneau; Matthew Hickman
Journal:  Cochrane Database Syst Rev       Date:  2017-09-18

3.  Drug Use Disorders and Violence: Associations With Individual Drug Categories.

Authors:  Shaoling Zhong; Rongqin Yu; Seena Fazel
Journal:  Epidemiol Rev       Date:  2020-01-31       Impact factor: 6.222

4.  Comorbid opioid use is undertreated among forensic patients with schizophrenia.

Authors:  Kristiina Kivimies; Eila Repo-Tiihonen; Hannu Kautiainen; Jari Tiihonen
Journal:  Subst Abuse Treat Prev Policy       Date:  2018-11-06

5.  Problematic Opioid Use: A Scoping Literature Review of Profiles.

Authors:  Léonie Archambault; Karine Bertrand; Michel Perreault
Journal:  Subst Abuse       Date:  2022-07-28

6.  Offending, custody and opioid substitution therapy treatment utilisation among opioid-dependent people in contact with the criminal justice system: comparison of Indigenous and non-Indigenous Australians.

Authors:  Natasa Gisev; Amy Gibson; Sarah Larney; Jo Kimber; Megan Williams; Anton Clifford; Michael Doyle; Lucy Burns; Tony Butler; Don J Weatherburn; Louisa Degenhardt
Journal:  BMC Public Health       Date:  2014-09-06       Impact factor: 3.295

7.  Factors Associated with Relapse among Heroin Addicts: Evidence from a Two-Year Community-Based Follow-Up Study in China.

Authors:  Chao Rong; Hai-Feng Jiang; Rui-Wen Zhang; Li-Juan Zhang; Jian-Chen Zhang; Jing Zhang; Xue-Shan Feng
Journal:  Int J Environ Res Public Health       Date:  2016-01-28       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.